Funding Opportunities
CSNK2A1 Pilot Grant Program Now Accepting Applications through April 17th, 2026!
The CSNK2A1 Foundation, in collaboration with the Orphan Disease Center, is funding one pilot project to advance understanding of Okur–Chung Neurodevelopmental Syndrome (OCNDS) and support therapeutic development.
Award: Up to $50,000 for 1 year
Research Focus Areas
Projects must be relevant to CSNK2A1 biology and OCNDS and align with one or more of the following:
- Disease Mechanisms
- Variant-level biology, CK2 function, and cellular or molecular pathways
- Biomarkers
- Discovery or validation of molecular, physiological, or digital biomarkers to support trial readiness
- Therapeutics
- Drug repurposing, gene/RNA-based strategies, or pathway-targeted approaches
Community-prioritized domains include communication, cognition, sleep, and anxiety.
Eligibility
- Open to faculty-level investigators or senior researchers at academic or non-profit institutions.
- No prior CSNK2A1 experience required.
How to Apply
A one-page Letter of Interest (LOI) is required.
Deadline: Friday, April 17, 2026 (8:00 PM EST)
Our Research Funding Approach
The CSNK2A1 Foundation supports high-impact research aligned with community priorities and therapeutic development. While funding opportunities vary over time, our focus remains on advancing disease understanding, building research resources, and accelerating treatment development.
Researchers interested in working with the Foundation are encouraged to monitor this page for future funding opportunities. We are not currently accepting unsolicited proposals.
We focus funding on two types of grants:
01 Research Grants
- proposals investigating CSNK2A1 that aim to improve our understanding of OCNDS and/or move us closer to treatment options.
02 Resource-Building Grants
- building research resources that will benefit the OCNDS research community (examples include but are not limited to: mouse models, cell lines, sequencing data etc.)
The Chief Scientific Officer and the Scientific Advisory Board of the CSNK2A1 Foundation review all research proposals and projects under consideration by the Foundation.
Proposals are evaluated based on:
- research objectives
- investigator's expertise
- the project's potential to accelerate the development of treatments for OCNDS patients
Open Opportunities
Currently, we are not accepting proposals.
IMPORTANT:
Please note that the CSNK2A1 Foundation does not fund indirect costs, also known as overhead or facilities and administrative (F&A) costs. Our policy stipulates that all grant funds must be allocated exclusively toward program expenses essential for grant execution and directly aligned with the project's objectives.